Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high …

A Raza, S Buonamici, L Lisak, S Tahir, D Li, M Imran… - Leukemia research, 2004 - Elsevier
Twenty-eight myelodysplastic syndromes (MDS) patients were treated with arsenic trioxide
(ATO) and thalidomide. Seven patients responded including one complete hematologic and …
被引用次数：121 相关文章
[PDF] academia.edu

[PDF][PDF] Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with …

A Razaa, S Buonamicib, L Lisaka, S Tahira… - Leukemia …, 2004 - academia.edu
Twenty-eight myelodysplastic syndromes (MDS) patients were treated with arsenic trioxide
(ATO) and thalidomide. Seven patients responded including one complete hematologic and …

Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high …

A Raza, S Buonamici, L Lisak, S Tahir, D Li… - Leukemia …, 2004 - europepmc.org
Twenty-eight myelodysplastic syndromes (MDS) patients were treated with arsenic trioxide
(ATO) and thalidomide. Seven patients responded including one complete hematologic and …

Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high …

A Raza, S Buonamici, L Lisak, S Tahir, D Li, M Imran… - Leukemia Research, 2004 - infona.pl
Twenty-eight myelodysplastic syndromes (MDS) patients were treated with arsenic trioxide
(ATO) and thalidomide. Seven patients responded including one complete hematologic and …

[引用][C] Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with …

A RAZA - Leuk Res, 2004 - cir.nii.ac.jp
Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses
in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 …

Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high …

A Raza, S Buonamici, L Lisak, S Tahir, D Li… - LEUKEMIA …, 2004 - iris.unimore.it
Twenty-eight myelodysplastic syndromes (MDS) patients were treated with arsenic trioxide
(ATO) and thalidomide. Seven patients responded including one complete hematologic and …

Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high …

A Raza, S Buonamici, L Lisak, S Tahir… - Leuk …, 2004 - medicinacomplementar.com.br
Twenty-eight myelodysplastic syndromes (MDS) patients were treated with arsenic trioxide
(ATO) and thalidomide. Seven patients responded including one complete hematologic and …

Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high …

A Raza, S Buonamici, L Lisak, S Tahir… - Leukemia …, 2004 - pubmed.ncbi.nlm.nih.gov
Twenty-eight myelodysplastic syndromes (MDS) patients were treated with arsenic trioxide
(ATO) and thalidomide. Seven patients responded including one complete hematologic and …
[PDF] academia.edu

[PDF][PDF] Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with …

A Razaa, S Buonamicib, L Lisaka, S Tahira… - Leukemia …, 2004 - academia.edu
Twenty-eight myelodysplastic syndromes (MDS) patients were treated with arsenic trioxide
(ATO) and thalidomide. Seven patients responded including one complete hematologic and …

[引用][C] Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with …

A Raza, S Buonamici, L Lisak, S Tahir, D Li… - Leukemia …, 2004 - cir.nii.ac.jp
Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses
in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 …